December 2013 - Volume 33 - Issue 6
pp: 725-866
Subscribe to eTOC



Population Pharmacokinetic-Pharmacodynamic Modeling of Haloperidol in Patients With Schizophrenia Using Positive and Negative Syndrome Rating Scale

Pilla Reddy, Venkatesh; Kozielska, Magdalena; Johnson, Martin; More

Journal of Clinical Psychopharmacology . 33(6):731-739, December 2013.

Acute Effects of Single-Dose Olanzapine on Metabolic, Endocrine, and Inflammatory Markers in Healthy Controls

Hahn, Margaret Karolina; Wolever, Tom M.S.; Arenovich, Tamara; More

Journal of Clinical Psychopharmacology . 33(6):740-746, December 2013.

Long-Term Quality-of-Life and Functioning Comparison of Atomoxetine Versus Other Standard Treatment in Pediatric Attention-Deficit/Hyperactivity Disorder

Fuentes, Joaquin; Danckaerts, Marina; Cardo, Esther; More

Journal of Clinical Psychopharmacology . 33(6):766-774, December 2013.

Risk of Perioperative Blood Transfusions and Postoperative Complications Associated With Serotonergic Antidepressants in Older Adults Undergoing Hip Fracture Surgery

Seitz, Dallas P.; Bell, Chaim M.; Gill, Sudeep S.; More

Journal of Clinical Psychopharmacology . 33(6):790-798, December 2013.



Brain-Derived Neurotrophic Factor Serum Concentrations in Acute Depressive Patients Increase During Lithium Augmentation of Antidepressants

Ricken, Roland; Adli, Mazda; Lange, Claudia; More

Journal of Clinical Psychopharmacology . 33(6):806-809, December 2013.


Mirtazapine Add-On Improves Olanzapine Effect on Negative Symptoms of Schizophrenia

Caforio, Grazia; Di Giorgio, Annabella; Rampino, Antonio; More

Journal of Clinical Psychopharmacology . 33(6):810-812, December 2013.

A Randomized, Double-Blind Comparison of Atomoxetine and Placebo on Response Inhibition and Interference Control in Children and Adolescents With Autism Spectrum Disorder and...

van der Meer, Jolanda M.J.; Harfterkamp, Myriam; van de Loo-Neus, Gigi; More

Journal of Clinical Psychopharmacology . 33(6):824-827, December 2013.